Inventory

12 Months Ended

Dec. 31, 2021

Inventory Disclosure [Abstract]

Inventory

Inventory

The Company commenced the capitalization of QINLOCK inventory in May 2020 upon receiving FDA approval of QINLOCK.

Capitalized inventory consisted of the following:

(in thousands)	December 31, 2021		December 31, 2020
Raw materials	$	4,721	$	1,352
Work in process	7,925		4,142
Finished goods	1,479		222
Total inventory	$	14,125	$	5,716

Inventory written down as a result of excess, obsolescence, unmarketability, or other reasons is charged to cost of sales, and totaled less than $0.1 million during the year ended December 31, 2021. There were no inventory amounts written down and charged to cost of sales during the year ended December 31, 2020.